Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of an efficient approach to boost fused deposition modeling (FDM) printing of felodipine-HPMC tablets for enhanced physical stability.

International journal of pharmaceutics: X·2025
Same author

Computational and experimental exploration of statin and statin-like compounds as potential treatment of schistosomiasis.

PLoS neglected tropical diseases·2025
Same author

CGeNArateWeb: a web server for the atomistic study of the structure and dynamics of chromatin fibers.

Nucleic acids research·2025
Same author

Protein Oxidative Modifications in Neurodegenerative Diseases: From Advances in Detection and Modelling to Their Use as Disease Biomarkers.

Antioxidants (Basel, Switzerland)·2024
Same author

CGeNArate: a sequence-dependent coarse-grained model of DNA for accurate atomistic MD simulations of kb-long duplexes.

Nucleic acids research·2024
Same author

Optimizing Excipient Properties to Prevent Aggregation in Biopharmaceutical Formulations.

Journal of chemical information and modeling·2023

Related Experiment Video

Updated: Jun 17, 2026

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents
06:43

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents

Published on: August 31, 2013

Molecular modelling methods to quantitate drug-DNA interactions.

Hao Wang1, Charles A Laughton

  • 1Department of Oral and Dental Science, University of Bristol, Bristol, UK.

Methods in Molecular Biology (Clifton, N.J.)
|December 10, 2009
PubMed
Summary

We present a molecular modeling approach to predict how strongly ligands bind to DNA. This method uses molecular dynamics simulations to calculate binding free energies, aiding in understanding sequence selectivity for minor-groove binders.

More Related Videos

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)
10:05

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)

Published on: January 20, 2016

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: Jun 17, 2026

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents
06:43

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents

Published on: August 31, 2013

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)
10:05

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)

Published on: January 20, 2016

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Area of Science:

  • Computational chemistry
  • Molecular dynamics
  • Drug discovery

Background:

  • Predicting ligand-DNA interactions is crucial for drug development.
  • Understanding sequence selectivity enhances targeted therapies.
  • Molecular modeling offers a computational approach to study these interactions.

Purpose of the Study:

  • To introduce a novel molecular modeling method for calculating ligand-DNA binding affinity.
  • To focus on predicting sequence selectivity for minor-groove binding ligands.
  • To provide a framework for applying molecular dynamics (MD) simulations to this problem.

Main Methods:

  • Utilizing molecular dynamics (MD) simulations of DNA sequences with and without bound ligands.
  • Postprocessing MD trajectory data to derive approximate free energies of binding.
  • Addressing critical aspects of structure preparation and simulation parameter selection.

Main Results:

  • The described method provides a computational route to estimate binding affinities.
  • It allows for the assessment of sequence selectivity in ligand-DNA interactions.
  • The study details considerations for simulation reliability and data analysis.

Conclusions:

  • This molecular modeling approach offers a valuable tool for predicting ligand-DNA binding.
  • It facilitates the design of sequence-specific DNA-binding agents.
  • The methodology is adaptable for various noncovalent interactions.